Cargando…

An Inducible Cell-Cell Fusion System with Integrated Ability to Measure the Efficiency and Specificity of HIV-1 Entry Inhibitors

HIV-1 envelope glycoproteins (Envs) mediate virus entry by fusing the viral and target cell membranes, a multi-step process that represents an attractive target for inhibition. Entry inhibitors with broad-range activity against diverse isolates of HIV-1 may be extremely useful as lead compounds for...

Descripción completa

Detalles Bibliográficos
Autores principales:	Herschhorn, Alon, Finzi, Andres, Jones, David M., Courter, Joel R., Sugawara, Akihiro, Smith, Amos B., Sodroski, Joseph G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2011
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3206054/ https://www.ncbi.nlm.nih.gov/pubmed/22069466 http://dx.doi.org/10.1371/journal.pone.0026731

Ejemplares similares

A broad HIV-1 inhibitor blocks envelope glycoprotein transitions critical for entry
por: Herschhorn, Alon, et al.
Publicado: (2014)

An entry-competent intermediate state of the HIV-1 envelope glycoproteins
por: Herschhorn, Alon, et al.
Publicado: (2017)

Release of gp120 Restraints Leads to an Entry-Competent Intermediate State of the HIV-1 Envelope Glycoproteins
por: Herschhorn, Alon, et al.
Publicado: (2016)

Structure-Based Design, Synthesis and Validation of CD4-Mimetic Small Molecule Inhibitors of HIV-1 Entry: Conversion of a Viral Entry Agonist to an Antagonist
por: Courter, Joel R., et al.
Publicado: (2014)

Molecular architecture of the uncleaved HIV-1 envelope glycoprotein trimer
por: Mao, Youdong, et al.
Publicado: (2013)

Crystal structures of trimeric HIV Env with entry inhibitors BMS-378806 and BMS-626529
por: Pancera, Marie, et al.
Publicado: (2017)

Visualization of HIV-1 RNA Transcription from Integrated HIV-1 DNA in Reactivated Latently Infected Cells
por: Ukah, Obiaara B., et al.
Publicado: (2018)

Small CD4 Mimetics Prevent HIV-1 Uninfected Bystander CD4 + T Cell Killing Mediated by Antibody-dependent Cell-mediated Cytotoxicity
por: Richard, Jonathan, et al.
Publicado: (2015)

540. Investigating the Mechanism of a Unique Human Immunodeficiency Virus-1 (HIV-1) Entry Inhibitor, MF275
por: Zhao, Connie, et al.
Publicado: (2018)

Subunit organization of the membrane-bound HIV-1 envelope glycoprotein trimer
por: Mao, Youdong, et al.
Publicado: (2012)

HIV-1 Entry and Membrane Fusion Inhibitors
por: Xiao, Tianshu, et al.
Publicado: (2021)

Contribution of Intrinsic Reactivity of the HIV-1 Envelope Glycoproteins to CD4-Independent Infection and Global Inhibitor Sensitivity
por: Haim, Hillel, et al.
Publicado: (2011)

Effects of the I559P gp41 Change on the Conformation and Function of the Human Immunodeficiency Virus (HIV-1) Membrane Envelope Glycoprotein Trimer
por: Alsahafi, Nirmin, et al.
Publicado: (2015)

Intra- and extra-cellular environments contribute to the fate of HIV-1 infection
por: Ratnapriya, Sneha, et al.
Publicado: (2021)

Blockade of HIV-1 Infection of New World Monkey Cells Occurs Primarily at the Stage of Virus Entry
por: LaBonte, Jason A., et al.
Publicado: (2002)

Lattice engineering enables definition of molecular features allowing for potent small-molecule inhibition of HIV-1 entry
por: Lai, Yen-Ting, et al.
Publicado: (2019)

A Protocol for Studying HIV-1 Envelope Glycoprotein Function
por: Ratnapriya, Sneha, et al.
Publicado: (2020)

The β20–β21 of gp120 is a regulatory switch for HIV-1 Env conformational transitions
por: Herschhorn, Alon, et al.
Publicado: (2017)

Crystal Structures of HIV-1 gp120 Envelope Glycoprotein in Complex with NBD Analogues That Target the CD4-Binding Site
por: Kwon, Young Do, et al.
Publicado: (2014)

Characterization of two distinct early post-entry blocks to HIV-1 in common marmoset lymphocytes
por: Pacheco, Beatriz, et al.
Publicado: (2016)

Publisher Correction: The β20–β21 of gp120 is a regulatory switch for HIV-1 Env conformational transitions
por: Herschhorn, Alon, et al.
Publicado: (2018)

Evaluation of the contribution of the transmembrane region to the ectodomain conformation of the human immunodeficiency virus (HIV-1) envelope glycoprotein
por: Nguyen, Hanh T., et al.
Publicado: (2017)

HIV-1 anchor inhibitors and membrane fusion inhibitors target distinct but overlapping steps in virus entry
por: Eggink, Dirk, et al.
Publicado: (2019)

Flavivirus Cell Entry and Membrane Fusion
por: Smit, Jolanda M., et al.
Publicado: (2011)

SERINC5 Restricts HIV-1 Infectivity by Promoting Conformational Changes and Accelerating Functional Inactivation of Env
por: Kirschman, Junghwa, et al.
Publicado: (2022)

Correction: HIV-1 anchor inhibitors and membrane fusion inhibitors target distinct but overlapping steps in virus entry
por: Eggink, Dirk, et al.
Publicado: (2022)

Soluble CD4 and CD4-Mimetic Compounds Inhibit HIV-1 Infection by Induction of a Short-Lived Activated State
por: Haim, Hillel, et al.
Publicado: (2009)

Progress in the Identification of Dengue Virus Entry/Fusion Inhibitors
por: De La Guardia, Carolina, et al.
Publicado: (2014)

Design of a Bispecific HIV Entry Inhibitor Targeting the Cell Receptor CD4 and Viral Fusion Protein Gp41
por: Yan, Hongxia, et al.
Publicado: (2022)

Uncovering HIV-1-infected cells
por: Veillette, Maxime, et al.
Publicado: (2015)

HIV-1 Entry, Inhibitors, and Resistance
por: Lobritz, Michael A., et al.
Publicado: (2010)

Co-receptor Binding Site Antibodies Enable CD4-Mimetics to Expose Conserved Anti-cluster A ADCC Epitopes on HIV-1 Envelope Glycoproteins
por: Richard, Jonathan, et al.
Publicado: (2016)

Closing two doors of viral entry: Intramolecular combination of a coreceptor- and fusion inhibitor of HIV-1
por: Kopetzki, Erhard, et al.
Publicado: (2008)

MiRNA-103 downmodulates CCR5 expression reducing human immunodeficiency virus type-1 entry and impacting latency establishment in CD4(+) T cells
por: Bellini, Nicolas, et al.
Publicado: (2022)

Entry of Enveloped Viruses into Host Cells: Membrane Fusion
por: Más, Vicente, et al.
Publicado: (2013)

Structure-function analyses reveal key molecular determinants of HIV-1 CRF01_AE resistance to the entry inhibitor temsavir
por: Prévost, Jérémie, et al.
Publicado: (2023)

Entry Inhibitors: Efficient Means to Block Viral Infection
por: Pattnaik, Gourab Prasad, et al.
Publicado: (2020)

Opening the door on entry inhibitors in HIV: Redefining the use of entry inhibitors in heavily treatment experienced and treatment‐limited individuals living with HIV
por: Orkin, Chloe, et al.
Publicado: (2022)

Spike Glycoprotein and Host Cell Determinants of SARS-CoV-2 Entry and Cytopathic Effects
por: Nguyen, Hanh T., et al.
Publicado: (2021)

Paramyxovirus Fusion and Entry: Multiple Paths to a Common End
por: Chang, Andres, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_a9jp05t0m96f237g4ksa7eonlu